• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

小肠原发性腺癌的预后因素:单机构13年经验

Prognostic factors in primary adenocarcinoma of the small intestine: 13-year single institution experience.

作者信息

Chaiyasate Kongkrit, Jain Akhilesh K, Cheung Laurence Y, Jacobs Michael J, Mittal Vijay K

机构信息

Department of Surgery, Providence Hospital and Medical Centers, Southfield, Michigan 48075, USA.

出版信息

World J Surg Oncol. 2008 Jan 31;6:12. doi: 10.1186/1477-7819-6-12.

DOI:10.1186/1477-7819-6-12
PMID:18237404
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2253527/
Abstract

BACKGROUND

Adenocarcinoma of the small bowel is a relatively rare malignancy as compared to the other malignancies of the gastrointestinal tract. Nonspecific presentation and infrequent occurrence often leads to a delay in diagnosis and consequent poor prognosis. Various other factors are of prognostic importance while managing these tumors.

METHODS

The medical records of a total of 27 patients treated for adenocarcinoma of the small bowel at Providence Hospital and Medical Centers from year 1990 through 2003 were reviewed retrospectively. Data were analyzed using SPSS software (version 10.0; SPSS, Inc., Chicago, IL). Survival analyses were calculated using the Kaplan Meier method with the log rank test to assess the statistical significance. The socio-demographics (age, gender) were calculated using frequency analyses.

RESULTS

The patients included nine males and eighteen females with a median age at diagnosis of 62 years. Only 48% of the patients had an accurate preoperative diagnosis while another 33% had a diagnosis suspicious of small bowel malignancy. None of the patients presented in stage 1. The cumulative five-year survival was 30% while the median survival was 3.3 years. There was no 30-day mortality in the postoperative period in our series.

CONCLUSION

The univariate analysis demonstrated that tumor grade, stage at presentation, lymph nodal metastasis and resection margins were significant predictors of survival.

摘要

背景

与胃肠道的其他恶性肿瘤相比,小肠腺癌是一种相对罕见的恶性肿瘤。非特异性表现和发病率低常常导致诊断延迟,进而预后不良。在处理这些肿瘤时,其他各种因素对预后也很重要。

方法

回顾性分析了1990年至2003年在普罗维登斯医院及医疗中心接受小肠腺癌治疗的27例患者的病历。使用SPSS软件(版本10.0;SPSS公司,伊利诺伊州芝加哥)进行数据分析。采用Kaplan-Meier方法和对数秩检验计算生存分析,以评估统计学意义。使用频率分析计算社会人口统计学特征(年龄、性别)。

结果

患者包括9名男性和18名女性,诊断时的中位年龄为62岁。只有48%的患者术前诊断准确,另有33%的患者诊断怀疑为小肠恶性肿瘤。没有患者处于1期。累积五年生存率为30%,中位生存期为3.3年。在我们的系列研究中,术后30天内无死亡病例。

结论

单因素分析表明,肿瘤分级、就诊时分期、淋巴结转移和切缘是生存的重要预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/f10bea986e4a/1477-7819-6-12-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/1ae151c8d1a6/1477-7819-6-12-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/dde237ee848e/1477-7819-6-12-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/8f60dfa1b28c/1477-7819-6-12-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/05e4be9c05f0/1477-7819-6-12-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/b9bd60317d08/1477-7819-6-12-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/f10bea986e4a/1477-7819-6-12-6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/1ae151c8d1a6/1477-7819-6-12-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/dde237ee848e/1477-7819-6-12-2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/8f60dfa1b28c/1477-7819-6-12-3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/05e4be9c05f0/1477-7819-6-12-4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/b9bd60317d08/1477-7819-6-12-5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a934/2253527/f10bea986e4a/1477-7819-6-12-6.jpg

相似文献

1
Prognostic factors in primary adenocarcinoma of the small intestine: 13-year single institution experience.小肠原发性腺癌的预后因素:单机构13年经验
World J Surg Oncol. 2008 Jan 31;6:12. doi: 10.1186/1477-7819-6-12.
2
Prognostic clinicopathological factors after curative resection of small bowel adenocarcinoma.小肠腺癌根治性切除术后的预后临床病理因素
J Gastrointest Cancer. 2012 Jun;43(2):272-8. doi: 10.1007/s12029-011-9290-0.
3
Adenocarcinoma of the small bowel: a study of 37 cases with emphasis on histologic prognostic factors.小肠腺癌:一项对37例病例的研究,重点关注组织学预后因素。
Dis Colon Rectum. 2002 Nov;45(11):1496-502. doi: 10.1097/01.DCR.0000034134.49346.5E.
4
Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.小肠腺癌:217例患者的临床表现、预后因素及结局
Cancer. 2004 Aug 1;101(3):518-26. doi: 10.1002/cncr.20404.
5
Surgically treated primary malignant tumor of small bowel: a clinical analysis.手术治疗小肠原发性恶性肿瘤:临床分析。
World J Gastroenterol. 2010 Mar 28;16(12):1527-32. doi: 10.3748/wjg.v16.i12.1527.
6
Prognostic factors of primary small bowel adenocarcinoma: univariate and multivariate analysis.原发性小肠腺癌的预后因素:单因素和多因素分析
World J Surg. 2006 Mar;30(3):391-8; discussion 399. doi: 10.1007/s00268-005-7898-6.
7
New aspects of prognostic factors in adenocarcinomas of the small bowel.小肠腺癌预后因素的新进展。
Hepatogastroenterology. 2001 May-Jun;48(39):727-32.
8
Novel Prognostic Factors in Resected Small Bowel Adenocarcinoma.切除的小肠腺癌的新预后因素。
Clin Colorectal Cancer. 2019 Sep;18(3):218-225. doi: 10.1016/j.clcc.2019.05.002. Epub 2019 May 15.
9
Surgical treatment of small bowel cancer: a 20-year single institution experience.小肠癌的外科治疗:一项为期20年的单机构经验。
J Gastrointest Surg. 2003 Nov;7(7):925-30. doi: 10.1007/s11605-003-0042-8.
10
Evaluation of Prognostic Factors and Adjuvant Chemotherapy in Patients With Small Bowel Adenocarcinoma Who Underwent Curative Resection.评价接受根治性切除术的小肠腺癌患者的预后因素和辅助化疗。
Clin Colorectal Cancer. 2017 Sep;16(3):220-227. doi: 10.1016/j.clcc.2016.08.002. Epub 2016 Aug 30.

引用本文的文献

1
Primitive Resectable Small Bowel Cancer Clinical-Pathological Analysis: A 10-Year Retrospective Study in a General Surgery Unit.原发性可切除小肠癌的临床病理分析:普通外科病房的一项10年回顾性研究
Cancers (Basel). 2024 Nov 4;16(21):3713. doi: 10.3390/cancers16213713.
2
Bibliometrics analysis on the research status and trends of small bowel adenocarcinoma: 1923-2023.1923 - 2023年小肠腺癌研究现状与趋势的文献计量学分析
Front Oncol. 2024 Aug 21;14:1407315. doi: 10.3389/fonc.2024.1407315. eCollection 2024.
3
Characteristics and outcomes of small bowel adenocarcinoma: 14 years of experience at a single tertiary hospital in Saudi Arabia.

本文引用的文献

1
Cancer statistics, 2006.2006年癌症统计数据。
CA Cancer J Clin. 2006 Mar-Apr;56(2):106-30. doi: 10.3322/canjclin.56.2.106.
2
Adenocarcinoma of the small bowel: presentation, prognostic factors, and outcome of 217 patients.小肠腺癌:217例患者的临床表现、预后因素及结局
Cancer. 2004 Aug 1;101(3):518-26. doi: 10.1002/cncr.20404.
3
Primary tumors of the small bowel: diagnosis, treatment and prognostic factors.小肠原发性肿瘤:诊断、治疗及预后因素
小肠腺癌的特征与转归:沙特阿拉伯一家三级医院14年的经验
Mol Clin Oncol. 2023 Jan 27;18(3):17. doi: 10.3892/mco.2023.2613. eCollection 2023 Mar.
4
Small Bowel Adenocarcinoma: A Rare Case of Iron Deficiency Anemia.小肠腺癌:缺铁性贫血的罕见病例
Cureus. 2022 Dec 20;14(12):e32724. doi: 10.7759/cureus.32724. eCollection 2022 Dec.
5
Outcomes of Patients with Small Intestine Adenocarcinoma in a Canadian Province: A Retrospective Multi-Center Population-Based Cohort Study.加拿大某省小肠腺癌患者的预后:一项基于人群的回顾性多中心队列研究
Cancers (Basel). 2022 May 24;14(11):2581. doi: 10.3390/cancers14112581.
6
Small bowel adenocarcinoma: An overview.小肠腺癌:概述
World J Gastrointest Oncol. 2022 Feb 15;14(2):413-422. doi: 10.4251/wjgo.v14.i2.413.
7
Primary small bowel adenocarcinoma with loss of nuclear expression of PMS2 after resection of mucinous cholangiocarcinoma.黏液性胆管癌切除术后出现PMS2核表达缺失的原发性小肠腺癌。
J Surg Case Rep. 2022 Jan 31;2022(1):rjab628. doi: 10.1093/jscr/rjab628. eCollection 2022 Jan.
8
Findings beyond Crohn's disease encountered on magnetic resonance enterography: a pictorial review of diseases inside and outside the bowel.磁共振小肠造影发现的克罗恩病以外的病变:肠内外疾病的影像综述
Singapore Med J. 2021 Apr;62(4):173-181. doi: 10.11622/smedj.2021038.
9
The risk of small bowel adenocarcinoma in patients with Crohn's disease.克罗恩病患者患小肠腺癌的风险。
Prz Gastroenterol. 2020;15(4):309-313. doi: 10.5114/pg.2020.101559. Epub 2020 Dec 10.
10
Rare presentation of small bowel adenocarcinoma with neuroendocrine differentiation in the jejunum: A case report and summary of diagnostic and management options.空肠罕见的具有神经内分泌分化的小肠腺癌:一例报告及诊断与治疗选择总结
Mol Clin Oncol. 2019 Nov;11(5):461-464. doi: 10.3892/mco.2019.1925. Epub 2019 Sep 23.
Hepatogastroenterology. 2003 Dec;50 Suppl 2:ccxvi-ccxviii.
4
Surgical treatment of small bowel cancer: a 20-year single institution experience.小肠癌的外科治疗:一项为期20年的单机构经验。
J Gastrointest Surg. 2003 Nov;7(7):925-30. doi: 10.1007/s11605-003-0042-8.
5
PRIMARY TUMORS OF THE SMALL INTESTINE.小肠原发性肿瘤
Arch Surg. 1965 Sep;91:452-5. doi: 10.1001/archsurg.1965.01320150082012.
6
Tumors of the small intestine.小肠肿瘤
N Engl J Med. 1959 Feb 26;260(9):397-408. doi: 10.1056/NEJM195902262600901.
7
Duodenal cancer in patients with familial adenomatous polyposis (FAP): results of a 10 year prospective study.家族性腺瘤性息肉病(FAP)患者的十二指肠癌:一项10年前瞻性研究的结果
Gut. 2002 May;50(5):636-41. doi: 10.1136/gut.50.5.636.
8
New aspects of prognostic factors in adenocarcinomas of the small bowel.小肠腺癌预后因素的新进展。
Hepatogastroenterology. 2001 May-Jun;48(39):727-32.
9
Primary duodenal adenocarcinoma: a 40-year experience.原发性十二指肠腺癌:40年经验总结
Arch Surg. 2000 Sep;135(9):1070-4; discussion 1074-5. doi: 10.1001/archsurg.135.9.1070.
10
What prognostic factors are important in duodenal adenocarcinoma?十二指肠腺癌中哪些预后因素很重要?
Arch Surg. 2000 Jun;135(6):635-41; discussion 641-2. doi: 10.1001/archsurg.135.6.635.